Spots Global Cancer Trial Database for 2nd line therapy
Every month we try and update this database with for 2nd line therapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer | NCT04614103 | Metastatic Non ... | LN-145 LN-145 | 18 Years - 70 Years | Iovance Biotherapeutics, Inc. | |
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer | NCT05361174 | Unresectable Me... Metastatic Mela... Stage III Non-s... Stage IV Non-sm... | IOV-4001 | 18 Years - | Iovance Biotherapeutics, Inc. | |
SPIRITT - Second-Line Panitumumab Irinotecan Treatment Trial | NCT00418938 | Cancer Colon Cancer Colorectal Canc... Metastatic Canc... Rectal Cancer Metastatic Colo... | Panitumumab Bevacizumab Leucovorin Irinotecan 5-Fluorouracil | 18 Years - | Amgen | |
SPIRITT - Second-Line Panitumumab Irinotecan Treatment Trial | NCT00418938 | Cancer Colon Cancer Colorectal Canc... Metastatic Canc... Rectal Cancer Metastatic Colo... | Panitumumab Bevacizumab Leucovorin Irinotecan 5-Fluorouracil | 18 Years - | Amgen | |
SPIRITT - Second-Line Panitumumab Irinotecan Treatment Trial | NCT00418938 | Cancer Colon Cancer Colorectal Canc... Metastatic Canc... Rectal Cancer Metastatic Colo... | Panitumumab Bevacizumab Leucovorin Irinotecan 5-Fluorouracil | 18 Years - | Amgen |